JPS5896098A - エリスロマイシンａ誘導体 - Google Patents

エリスロマイシンａ誘導体

Info

Publication number
JPS5896098A
JPS5896098A JP56195039A JP19503981A JPS5896098A JP S5896098 A JPS5896098 A JP S5896098A JP 56195039 A JP56195039 A JP 56195039A JP 19503981 A JP19503981 A JP 19503981A JP S5896098 A JPS5896098 A JP S5896098A
Authority
JP
Japan
Prior art keywords
compound
erythromycin
formula
fraction
compound shown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56195039A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6360033B2 (en, 2012
Inventor
Shigeo Morimoto
森本　繁夫
Yoko Takahashi
洋子 高橋
Yoshiaki Watanabe
渡辺　慶昭
Sadafumi Omura
大村　貞文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority to JP56195039A priority Critical patent/JPS5896098A/ja
Priority to EP82306085A priority patent/EP0081305B1/en
Priority to DE8282306085T priority patent/DE3263301D1/de
Priority to US06/444,171 priority patent/US4476298A/en
Publication of JPS5896098A publication Critical patent/JPS5896098A/ja
Publication of JPS6360033B2 publication Critical patent/JPS6360033B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP56195039A 1981-12-03 1981-12-03 エリスロマイシンａ誘導体 Granted JPS5896098A (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP56195039A JPS5896098A (ja) 1981-12-03 1981-12-03 エリスロマイシンａ誘導体
EP82306085A EP0081305B1 (en) 1981-12-03 1982-11-16 Erythromycin a derivatives
DE8282306085T DE3263301D1 (en) 1981-12-03 1982-11-16 Erythromycin a derivatives
US06/444,171 US4476298A (en) 1981-12-03 1982-11-24 Erythromycin A derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56195039A JPS5896098A (ja) 1981-12-03 1981-12-03 エリスロマイシンａ誘導体

Publications (2)

Publication Number Publication Date
JPS5896098A true JPS5896098A (ja) 1983-06-07
JPS6360033B2 JPS6360033B2 (en, 2012) 1988-11-22

Family

ID=16334517

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56195039A Granted JPS5896098A (ja) 1981-12-03 1981-12-03 エリスロマイシンａ誘導体

Country Status (4)

Country Link
US (1) US4476298A (en, 2012)
EP (1) EP0081305B1 (en, 2012)
JP (1) JPS5896098A (en, 2012)
DE (1) DE3263301D1 (en, 2012)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196041B (it) * 1984-03-08 1988-11-10 Pierrel Spa Emichetali di (8s)-8-fluoroeritromicine,il procedimento per la loro preparazione e le formulazioni adatte alla somministrazione orale che contengono i prodotti
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
US5175150A (en) * 1985-08-31 1992-12-29 Kitasato, Kenkyusho Erythromycin derivative
US4686207A (en) * 1985-11-12 1987-08-11 Abbott Laboratories Erythromycin A 11,12-carbonates and method of use
DE3782994T2 (de) 1986-09-18 1993-04-08 Taisho Pharma Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
US5872229A (en) 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
US5929219A (en) 1997-09-10 1999-07-27 Abbott Laboratories 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
US8014024B2 (en) * 2005-03-02 2011-09-06 Xerox Corporation Gray balance for a printing system of multiple marking engines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2653899A (en) * 1952-04-14 1953-09-29 Lilly Co Eli Erythromycin, its salts, and method of preparation
US3884904A (en) * 1973-06-21 1975-05-20 Abbott Lab 11-Substituted erythromycin B derivatives
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds

Also Published As

Publication number Publication date
DE3263301D1 (en) 1985-05-30
EP0081305B1 (en) 1985-04-24
US4476298A (en) 1984-10-09
JPS6360033B2 (en, 2012) 1988-11-22
EP0081305A1 (en) 1983-06-15

Similar Documents

Publication Publication Date Title
CA1239639A (en) Epimeric azahomoerythromycin a derivative and intermediates therefor
US4345069A (en) Deformyltylosin derivatives
JP2001500855A (ja) 抗菌活性を有する６―ｏ―置換ケトリド
JPS61103890A (ja) ６−０−メチルエリスロマイシンａ誘導体
JPH06199887A (ja) 新規なエリスロマイシン誘導体、それらの製造法及びそれらの薬剤としての用途
DE69505487T2 (de) Erythromycin-Derivate, Verfahren zur Herstellung und Verwendung als Arzneimittel
EP0827965B1 (en) Synthesis of 9-deoxo- 9a-aza 11,12-deoxy- 9a-methyl-9a-homoerythromycin A 11,12- hydrogenorthoborate dihydrate
US4526889A (en) Epimeric azahomoerythromycin A derivative, intermediates and method of use
AU710532B2 (en) 3-descladinose-2,3-anhydroerythromycin derivatives
EP0080818B1 (en) Erythromycin b derivatives
JPS58159499A (ja) 抗菌剤として有用な４″−エピエリスロマイシンａおよびその誘導体
JPS5896098A (ja) エリスロマイシンａ誘導体
DE2716533C3 (de) N-Acetylierte oder -halogenacetylierte Kanamycine A und B, Verfahren zu ihrer Herstellung und ihre Verwendung
JPH0692434B2 (ja) ９−デオキソ−８ａ−アザ−８ａ−アルキル−８ａ−ホモエリスロマイシンＡの４″誘導体の製造方法
US6140479A (en) Erythromycin a derivatives
EP0080819B1 (en) 11-0-alkylerythromycin a derivatives
JPH04504259A (ja) エリスロマイシン誘導体
JPH0312077B2 (en, 2012)
DE69217398T2 (de) Verfahren zur Herstellung von 9-deoxo-9(z)-hydroxyiminoerythromycin A
JPH0615557B2 (ja) ２’―デオキシ―２’―メチリデンシチジンの２水和物結晶
EP0508725A1 (en) Novel process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers
JP3227871B2 (ja) ６−ｏ−メチルエリスロマイシンａ誘導体
JPH02292295A (ja) エトポシドの製造方法
JPS632274B2 (en, 2012)
JPH03169889A (ja) タイロシン誘導体、その製造方法およびそれを含有する医薬組成物